General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Amgen Inc.(MODEST), Novo Nordisk Inc.(MODEST), Sanofi-Aventis(MODEST), HLS Therapeutics (MODEST), Novartis Corporation(MODEST)
CONSULTING FEES/HONORARIA: Amgen Inc.(MODEST), Novo Nordisk Inc.(MODEST), Sanofi-Aventis(MODEST), HLS Therapeutics (MODEST), Novartis Corporation(MODEST)
© 2025 American College of Cardiology Foundation. All rights reserved.
